These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17487292)

  • 21. The Cost-Effectiveness of Low-Cost Essential Antihypertensive Medicines for Hypertension Control in China: A Modelling Study.
    Gu D; He J; Coxson PG; Rasmussen PW; Huang C; Thanataveerat A; Tzong KY; Xiong J; Wang M; Zhao D; Goldman L; Moran AE
    PLoS Med; 2015 Aug; 12(8):e1001860. PubMed ID: 26241895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Which elderly patients should be considered for anti-hypertensive treatment? An evidence-based approach.
    Jackson R
    J Hum Hypertens; 1998 Sep; 12(9):607-13. PubMed ID: 9783489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of prevention on reducing the burden of cardiovascular disease.
    Kahn R; Robertson RM; Smith R; Eddy D
    Circulation; 2008 Jul; 118(5):576-85. PubMed ID: 18606915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Danish Cardiovascular Screening Trial (DANCAVAS): study protocol for a randomized controlled trial.
    Diederichsen AC; Rasmussen LM; Søgaard R; Lambrechtsen J; Steffensen FH; Frost L; Egstrup K; Urbonaviciene G; Busk M; Olsen MH; Mickley H; Hallas J; Lindholt JS
    Trials; 2015 Dec; 16():554. PubMed ID: 26637993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of the polypill versus risk assessment for prevention of cardiovascular disease.
    Ferket BS; Hunink MG; Khanji M; Agarwal I; Fleischmann KE; Petersen SE
    Heart; 2017 Apr; 103(7):483-491. PubMed ID: 28077465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term health outcomes of people with reduced kidney function in the UK: A modelling study using population health data.
    Schlackow I; Simons C; Oke J; Feakins B; O'Callaghan CA; Hobbs FDR; Lasserson D; Stevens RJ; Perera R; Mihaylova B
    PLoS Med; 2020 Dec; 17(12):e1003478. PubMed ID: 33326459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluating the prevalence, awareness, and control of hypertension, diabetes, and dyslipidemia in Korea using the NHIS-NSC database: A cross-sectional analysis.
    Boo S; Yoon YJ; Oh H
    Medicine (Baltimore); 2018 Dec; 97(51):e13713. PubMed ID: 30572503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia.
    Bunting BA; Smith BH; Sutherland SE
    J Am Pharm Assoc (2003); 2008; 48(1):23-31. PubMed ID: 18192127
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of diabetes and cardiovascular comorbidity in the Canadian Community Health Survey 2002-2003.
    Mo F; Pogany LM; Li FC; Morrison H
    ScientificWorldJournal; 2006 Jan; 6():96-105. PubMed ID: 16435038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime health and economic benefits of weight loss among obese persons.
    Oster G; Thompson D; Edelsberg J; Bird AP; Colditz GA
    Am J Public Health; 1999 Oct; 89(10):1536-42. PubMed ID: 10511836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incident diabetes, hypertension and dyslipidemia in a Manitoba First Nation.
    Riediger ND; Lukianchuk V; Bruce SG
    Int J Circumpolar Health; 2015; 74():27712. PubMed ID: 26297439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.
    Gaziano TA; Steyn K; Cohen DJ; Weinstein MC; Opie LH
    Circulation; 2005 Dec; 112(23):3569-76. PubMed ID: 16330698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of preventive health services in rheumatoid arthritis patients compared to a primary care patient population.
    Bili A; Schroeder LL; Ledwich LJ; Kirchner HL; Newman ED; Wasko MC
    Rheumatol Int; 2011 Sep; 31(9):1159-65. PubMed ID: 20349066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in Taiwan: an analysis of nationwide data for 2000-2009.
    Tseng LN; Tseng YH; Jiang YD; Chang CH; Chung CH; Lin BJ; Chuang LM; Tai TY; Sheu WH
    J Formos Med Assoc; 2012 Nov; 111(11):625-36. PubMed ID: 23217598
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China.
    Stevens W; Peneva D; Li JZ; Liu LZ; Liu G; Gao R; Lakdawalla DN
    BMC Health Serv Res; 2016 May; 16():175. PubMed ID: 27165638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease.
    Perreault S; Dorais M; Coupal L; Paradis G; Joffres MR; Grover SA
    CMAJ; 1999 May; 160(10):1449-55. PubMed ID: 10352634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
    Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
    BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of dyslipidemia and associated cardiovascular risk factors in northeast China: A cross-sectional study.
    Xing L; Jing L; Tian Y; Yan H; Zhang B; Sun Q; Dai D; Shi L; Liu D; Yang Z; Liu S
    Nutr Metab Cardiovasc Dis; 2020 Nov; 30(12):2262-2270. PubMed ID: 32988725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.